# NATCO Pharma Limited - Inspection Records

Source: https://www.keypedia.com/companies/natco-pharma-limited/4c97e2d8-0023-4572-966f-d396e8fecc05

> Inspection records and compliance data for NATCO Pharma Limited in Rangareddy, None. Access full analysis and detailed observations.

---

## Details

- Name: NATCO Pharma Limited
- FEI Number: 3004540906
- City: Rangareddy
- State: None
- Country Name: India
- Address Line 1: Pharma Division, Kothur Village
- Zip Code: None
- Facility Type: Manufacturer
- Business Operations: FDF MANUFACTURE

## Related Documents

- [EIR - NATCO Pharma Limited - 2025-06-19](https://www.keypedia.com/records/eir/natco-pharma-limited/15752826-391f-4aff-bfa9-bbb8405c68d4) — source: FDA, date: June 19, 2025
- [483 - NATCO Pharma Limited - 2025-06-19](https://www.keypedia.com/records/483/natco-pharma-limited/f7f3273d-2be6-4f68-9f8f-a170de0e988e) — source: FDA, date: June 19, 2025
- [FDA Inspection 1273711 - NATCO Pharma Limited - 2025-06-19](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/80aae95c-db8b-4043-b5c3-41597f602f4d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 19, 2025
- [483 - NATCO Pharma Limited - 2023-10-18](https://www.keypedia.com/records/483/natco-pharma-limited/10dc5409-7a8f-438a-84ec-a39ae77c0ab3) — source: FDA, date: October 18, 2023
- [483 - NATCO Pharma Limited - 2023-10-18](https://www.keypedia.com/records/483/natco-pharma-limited/692230d1-0594-4320-ba99-2ef453417bd4) — source: FDA, date: October 18, 2023
- [FDA Inspection 1220533 - NATCO Pharma Limited - 2023-10-18](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/490eaf04-f2ac-48ef-96c9-2879ca06696c) — source: FDA, date: October 18, 2023
- [FDA Inspection 1137171 - NATCO Pharma Limited - 2019-06-24](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/9c7b0cce-1acc-45b6-a00d-602bb1633ccd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 24, 2019
- [FDA Inspection 1095772 - NATCO Pharma Limited - 2019-06-06](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/ea855f48-56a5-4020-95b4-2e58b1a8caf2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 6, 2019
- [483 - NATCO Pharma Limited - 2019-06-05](https://www.keypedia.com/records/483/natco-pharma-limited/0bf5ef08-8bd5-4fcd-a591-64b19920b76d) — source: FDA, date: June 5, 2019
- [483 - NATCO Pharma Limited - 2017-01-24](https://www.keypedia.com/records/483/natco-pharma-limited/2a205475-5923-4695-9193-3ade2ddbebb2) — source: FDA, date: January 24, 2017
- [FDA Inspection 1011854 - NATCO Pharma Limited - 2017-01-24](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/6e9d6dc9-1872-4792-aa61-4d0ea396c351) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 24, 2017
- [FDA Inspection 880454 - NATCO Pharma Limited - 2014-05-23](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/abd681f2-ce54-4551-8971-47c1474bc884) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 23, 2014
- [FDA Inspection 762119 - NATCO Pharma Limited - 2011-11-18](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/57a12f0b-492e-4d21-af3a-fbf3b3e5ae79) — classification: No Action Indicated (NAI), source: FDA, date: November 18, 2011
- [FDA Inspection 569301 - NATCO Pharma Limited - 2009-02-12](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/3e086749-4111-4243-a02c-696e249d0123) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 12, 2009

## Related Companies

- [Emcure Pharmaceuticals Limited](https://www.keypedia.com/companies/emcure-pharmaceuticals-limited/d1295106-bf79-46f5-bf51-08338508f98e)
- [Ipca Laboratories Limited](https://www.keypedia.com/companies/ipca-laboratories-limited/8357cd13-53b4-4e4d-a2a5-54b750096c7a)
- [Ascent Pharmaceuticals Inc](https://www.keypedia.com/companies/ascent-pharmaceuticals-inc/a6df28ee-9e4e-4fae-8eed-dbe5eb870593)
- [Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)](https://www.keypedia.com/companies/vetter-pharma-fertigung-gmbh-co-kg-ravensburg-mooswiesen/d0287c3d-c544-40de-aece-ba713025286c)
- [Mylan Laboratories Limited](https://www.keypedia.com/companies/mylan-laboratories-limited/4fd10a2e-3696-4bd0-82aa-e875143028c0)
- [Kenvue Brands LLC](https://www.keypedia.com/companies/kenvue-brands-llc/69c27fd1-bbb9-4c3a-bbb5-4ac86be8e574)
- [Patheon Manufacturing Services LLC](https://www.keypedia.com/companies/patheon-manufacturing-services-llc/64087a9c-0f9c-44d7-aeb9-171f7bc13658)
- [Rechon Life Science AB](https://www.keypedia.com/companies/rechon-life-science-ab/ce84eed4-ada6-40a0-9005-2c2d6bbd729d)
- [Jubilant HollisterStier LLC](https://www.keypedia.com/companies/jubilant-hollisterstier-llc/2f8cb6dd-3555-4528-a2d6-d3b845d229ba)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/6b5864ed-07a2-4861-b424-021018d4f7e9)

## Related Officers

- [SVP Consulting & Operations](https://www.keypedia.com/people/linda-f-murphy/a8b9737f-d5f4-4a36-8684-2fb050d008f2)
- [Consumer Safety Officer ](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)
- [Patric C. Klotzbuecher](https://www.keypedia.com/people/patric-c-klotzbuecher/cbb2e6b5-b001-457e-9073-33535f02926e)
- [Investigator](https://www.keypedia.com/people/marcellinus-d-dordunoo/a0e35c24-0cf5-4b11-95ba-1693fa3ecb3a)
- [Saleem A. Akhtar](https://www.keypedia.com/people/saleem-a-akhtar/1ea49212-bea5-4d43-bd0a-cdede4d3b1cf)
- [Pratik S. Upadhyay](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)